Search
Showing results for "1"
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
Research
'If I Wanted to Have More Opportunities and Go to a Better School, I Just Had to Get Used to It’The experiences of 32 male Aboriginal students from regional and remote towns and communities while they attended a metropolitan boarding school...
News & Events
Research finds pumps deliver better long-term blood glucose controlNew research from the Children’s Diabetes Centre at The Kids Research Institute Australia has found children who use an insulin pump to manage their type 1 diabetes have better long-term blood glucose control than those on insulin injections.
News & Events
Ads clinic updateThe Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.
Research
Diet culture on TikTok: a descriptive content analysisTo investigate how dieting is portrayed on TikTok and the potential implications for public health considering the effect of diet culture on eating disorders amongst young people.
Research
The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1)While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the prod